Dr. Doroudian is an accomplished executive with over 25 years experience in management and development of private and publicly traded pharmaceutical companies. From 2009 to February 2014 he was the Founder, CEO and Director of Merus Labs Inc., a publicly listed specialty pharmaceutical company (MSL:TSX and MSLI:NASDAQ) engaged in licensing and acquisition of legacy brands and innovative near-market products. From 2003 to 2009 he was involved in early stage financing of private and publicly listed companies. From 1994 to 2002 Dr. Doroudian was the Founder and CEO of PanGeo (Pharmex Industries) where he assembled a team that completed over $100 MM in debt and equity and guided numerous acquisitions and licensing transactions. From 1990 to 1996 he was manager of operations at Novapharm (Teva), in charge of management of manufacturing, supply chain and process development facilities in Vancouver, British Columbia. Dr. Doroudian holds an M.Sc. in Pharmaceutics and a PhD in Biopharmaceutics (Pharmacokinetics and drug metabolism) from the University of British Columbia.
Pharmaceuticals and Business Development